The University of Warwick Library - WebBridge

Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M) : preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study
Corrie, Pippa G..  The Lancet Oncology.  v. Volume 15. no. Number 6.   2014-04-16. p. 620 - 630... issn: 1470-2045 .   

Online access not found

Sorry - based on the information provided, WebBridge cannot offer appropriate links.